# | Title | Journal | Year | Citations |
---|
1 | Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 181 |
2 | Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017 | European Heart Journal Quality of Care & Clinical Outcomes | 2022 | 154 |
3 | The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review | European Heart Journal Quality of Care & Clinical Outcomes | 2016 | 142 |
4 | Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017 | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 128 |
5 | New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome | European Heart Journal Quality of Care & Clinical Outcomes | 2018 | 122 |
6 | Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs | European Heart Journal Quality of Care & Clinical Outcomes | 2022 | 115 |
7 | The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 109 |
8 | Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction | European Heart Journal Quality of Care & Clinical Outcomes | 2016 | 88 |
9 | Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 82 |
10 | Barriers and facilitators to public access defibrillation in out-of-hospital cardiac arrest: a systematic review | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 77 |
11 | Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 75 |
12 | Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 69 |
13 | Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 66 |
14 | Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease | European Heart Journal Quality of Care & Clinical Outcomes | 2015 | 65 |
15 | The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis | European Heart Journal Quality of Care & Clinical Outcomes | 2016 | 65 |
16 | Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 64 |
17 | Cardiac rehabilitation fitness changes and subsequent survival | European Heart Journal Quality of Care & Clinical Outcomes | 2018 | 64 |
18 | Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 63 |
19 | Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 63 |
20 | Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 59 |
21 | The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 58 |
22 | Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 58 |
23 | The association of depression at any time to the risk of death following coronary artery disease diagnosis | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 56 |
24 | Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 54 |
25 | Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study | European Heart Journal Quality of Care & Clinical Outcomes | 2018 | 53 |
26 | The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 53 |
27 | European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes | European Heart Journal Quality of Care & Clinical Outcomes | 2022 | 52 |
28 | Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 52 |
29 | Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER) | European Heart Journal Quality of Care & Clinical Outcomes | 2016 | 49 |
30 | Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown? | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 49 |
31 | Big biomedical data and cardiovascular disease research: opportunities and challenges | European Heart Journal Quality of Care & Clinical Outcomes | 2015 | 48 |
32 | British Cardiovascular Intervention Society registry framework: a quality improvement initiative on behalf of the National Institute of Cardiovascular Outcomes Research (NICOR) | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 47 |
33 | Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry | European Heart Journal Quality of Care & Clinical Outcomes | 2022 | 47 |
34 | Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 45 |
35 | Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 44 |
36 | Natural history of patients with insignificant coronary artery disease | European Heart Journal Quality of Care & Clinical Outcomes | 2016 | 43 |
37 | Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 43 |
38 | Cardiovascular comorbidities as predictors for severe COVID-19 infection or death | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 43 |
39 | Cohort profile: the Myocardial Ischaemia National Audit Project (MINAP) | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 42 |
40 | Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta-analysis | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 42 |
41 | Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 42 |
42 | Characteristics of neighbourhoods with high incidence of out-of-hospital cardiac arrest and low bystander cardiopulmonary resuscitation rates in England | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 41 |
43 | Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 41 |
44 | Living alone is associated with all-cause and cardiovascular mortality: 32 years of follow-up in the Copenhagen Male Study | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 39 |
45 | A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation | European Heart Journal Quality of Care & Clinical Outcomes | 2019 | 39 |
46 | European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary) | European Heart Journal Quality of Care & Clinical Outcomes | 2020 | 39 |
47 | Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry | European Heart Journal Quality of Care & Clinical Outcomes | 2018 | 36 |
48 | Long-term survival and fate of the leg in de novo intermittent claudication | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 33 |
49 | Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies | European Heart Journal Quality of Care & Clinical Outcomes | 2017 | 33 |
50 | Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation | European Heart Journal Quality of Care & Clinical Outcomes | 2021 | 33 |